Raymond James Financial Services Advisors’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$37.1K Buy
2022
Q4
Sell
2022
Q3
$51K Sell
2022
Q2
$32K Sell
2022
Q1
$40K Hold
2021
Q4
$48K Sell
2021
Q3
$42K Sell
2021
Q2
$49K Sell
2021
Q1
$51K Buy
2020
Q4
$54K Buy